GILEAD SCIENCES, INC. Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
GILEAD SCIENCES, INC. (GILD) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of $7.60 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-04.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2011-11-04
- GILEAD SCIENCES, INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2011-09-30 was $149.20M.
- GILEAD SCIENCES, INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2011-06-30 was -$27.00M.
- GILEAD SCIENCES, INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2011-03-31 was -$114.60M.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 6 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 9 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month |
|---|---|---|---|---|
| 2011-09-30 | $149.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $122.20M derived: sum of 2 quarters · filed 2011-11-04 | $7.60M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | -$27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | -$141.60M 10-Q · filed 2011-08-05 | ||
| 2011-03-31 | -$114.60M 10-Q · filed 2011-05-09 | |||
| 2010-12-31 | $21.60M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |